NLRP3 and adenocarcinoma: In addition, studies have shown that the overexpression of miR-223 in human adenocarcinoma alveolar basal epithelial cells can reduce LPS-induced Caspase-1, IL-1β, and IL-18 levels by targeting NLRP3.